Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,890.00    130.00 (2.73%)
Bid:
4,894.00
Ask:
4,898.00
Spread: 4.00 (0.082%)
Market Cap: £17.82b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

4 Jan 2022 09:54

RNS Number : 3425X
Coca-Cola HBC AG
04 January 2022
 

FOR IMMEDIATE RELEASE

04 January 2022

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company announces that the deferred bonus award over shares of CHF 6.70 in the Company (the "Deferred Shares") granted under the Company's Management Incentive Plan to Zoran Bogdanovic, Chief Executive Officer, relating to a performance related annual bonus for 2018 vested on 31 December 2021. Following vesting, the PDMR sold sufficient Deferred Shares to cover his tax and other liabilities and the balance of the Deferred Shares was retained.

 PDMR

Number of shares granted under the Deferred Shares vesting

Number of shares sold to cover taxes and other liabilities

Number of shares retained

Zoran Bogdanovic, Chief Executive Officer

7,717

450

7,267

 

The Notification of Dealing Form can be found below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

ZORAN BOGDANOVIC

 

2

 

Reason for the notification

a)

 

Position/status

 

CHIEF EXECUTIVE OFFICER

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

VESTING OF DEFERRED SHARES GRANTED IN MARCH 2019 UNDER THE COMPANY'S MANAGEMENT INCENTIVE PLAN

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

25.47 GBP

7,717

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

25.47 GBP

7,717

196,551.99 GBP

e)

 

Date of the transaction

 

2021-12-31

f)

 

Place of the transaction

 

XLON

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

SALE OF SHARES TO COVER TAX AND OTHER LIABILITIES ARISING FROM VESTING OF THE DEFERRED SHARES

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

25.47 GBP

450

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

25.47 GBP

450

11,461.50 GBP

e)

 

Date of the transaction

 

2021-12-31

f)

 

Place of the transaction

 

XLON

 

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKQBPCBKKBDK
Date   Source Headline
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement
22nd Mar 20245:05 pmRNSTransaction in Own Shares
21st Mar 20245:40 pmRNSTransaction in Own Shares
20th Mar 20245:33 pmRNSTransaction in Own Shares
19th Mar 20245:20 pmRNSTransaction in Own Shares
19th Mar 20241:19 pmRNSDirector/PDMR Shareholding
18th Mar 20245:20 pmRNSTransaction in Own Shares
15th Mar 20246:25 pmRNSTransaction in Own Shares
15th Mar 20245:58 pmRNSAnnual Financial Report
14th Mar 20245:30 pmRNSTransaction in Own Shares
14th Mar 20243:04 pmRNSDirector/PDMR Shareholding
14th Mar 20242:56 pmRNSDirector/PDMR Shareholding
13th Mar 20245:20 pmRNSTransaction in Own Shares
12th Mar 20245:15 pmRNSTransaction in Own Shares
11th Mar 20245:50 pmRNSTransaction in Own Shares
8th Mar 20245:45 pmRNSTransaction in Own Shares
7th Mar 20245:20 pmRNSTransaction in Own Shares
6th Mar 20245:10 pmRNSTransaction in Own Shares
5th Mar 20245:15 pmRNSTransaction in Own Shares
4th Mar 20245:55 pmRNSTransaction in Own Shares
1st Mar 20245:15 pmRNSTransaction in Own Shares
1st Mar 20249:25 amRNSIssue of Equity and total voting rights
29th Feb 20245:25 pmRNSTransaction in Own Shares
29th Feb 20243:10 pmRNSDirector/PDMR Shareholding
29th Feb 20243:00 pmRNSDirector/PDMR Shareholding
29th Feb 20242:53 pmRNSDirector/PDMR Shareholding
28th Feb 20245:25 pmRNSTransaction in Own Shares
27th Feb 20245:35 pmRNSTransaction in Own Shares
26th Feb 20245:35 pmRNSTransaction in Own Shares
26th Feb 20241:31 pmRNSDirector/PDMR Shareholding
26th Feb 20247:15 amRNSTransaction in Own Shares
23rd Feb 20241:51 pmRNSFinal Terms - 2028 Notes
22nd Feb 20245:30 pmRNSTransaction in Own Shares
22nd Feb 20247:15 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSCoca-Cola HBC acquires BDS Vending in Ireland
20th Feb 20246:15 pmRNSTransaction in Own Shares
20th Feb 20244:01 pmRNSPricing of Issue of Notes
20th Feb 202410:47 amRNSDirector/PDMR Shareholding
20th Feb 20248:41 amRNSLaunch of Issue of Notes
19th Feb 20246:03 pmRNSTransaction in Own Shares
19th Feb 20244:50 pmRNSDirector/PDMR Shareholding
15th Feb 20242:59 pmRNSPublication of Suppl.Prospcts
14th Feb 20247:00 amRNSStrong execution powers a year of growth
7th Feb 20244:45 pmRNSAppointment of Group CFO
1st Feb 202411:35 amRNSIssue of equity and total voting rights
29th Jan 20241:58 pmRNSAppointment of Corporate Broker
18th Jan 20242:54 pmRNSDirector/PDMR Shareholding
18th Jan 20241:29 pmRNSNotice of Results
15th Jan 20244:45 pmRNSCFO stepping down to pursue new role in N. America

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.